Please assess the completion status of the following clinical trial:

Trial Title: Study to Examine the Safety and Effectiveness of Implanted Skeletal Muscle Cells (Cells Removed From the Thigh Muscle) Into Scarred Areas of Heart Muscle After Heart Attack.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients recommended for coronary bypass surgery (preferably with cardiopulmonary support)~* Ejection fraction ≥15% and ≤35%~* Left ventricular myocardial infarction (MI - heart attack) ≥4 weeks prior to screening~Exclusion Criteria:~* Need for a rapid surgical coronary revascularization~* Need for any other related cardiosurgical measure during coronary surgery (e.g. mitral valve repair or valve replacement)~* Patients with a left ventricular aneurysm who is a candidate for left ventricular aneurysmectomy or left ventricular reduction surgery; patient receiving left or biventricular (BiV) pacing therapy for heart failure (unless the patient has stabilized after 6 or more months of this therapy)~* Cardiomyopathy presumed to be of non-ischemic origin

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).